PharmaTell had Eyes on the US Baby Formula Shortage this week. I was curious as to how this happened

This was a busy week for Healthcare with 1Q22 Results. The PharmaTell Team had eyes on some of the US FDA decisions + Roche's SKYSCRAPER-01

The PharmaTell Team has been busy curating Quarterly Results reports & upcoming conference planners + keeping up with Biogen next steps.

This week the team has been enjoying the spring holidays and keeping their eyes on some of the recent news from AACR and learning a bit more

This week the team has been keeping their eyes on 1Q22 Patient Volume/Procedure Updates and the Aduhelm CMS Decision.

We are excited to share the latest upgrades to PharmaTell Studio making it even easier for you to keep your eyes on you & your competition.

This week, the team has been looking at congress planners, earnings call transcripts, and the US FDA.

This week, the team had Eyes on the new draft guidance from the US FDA on Gene Therapy Products Incorporating Genome Editing.

Today we’ll share some of the types of reports available that can help you keep your Eyes on Pharma Sectors.

We found several different types of intel so we thought we would share some with you – and tips on how to find it.

Check out the latest on some of the Opioid Litigation, SPACS, and yes two Top 10 Lists!

The Eyes on Pharma team was caught up in reviewing global R&D trends and following the updates from ASCO-GU ...